Faalcon concepts Limited has secured a new work order worth Rs. 2,86,53,745 from LV Creations LLP for glass, glazing and windows work at Aakash Hospital in New Delhi. The company announced this development through a regulatory filing under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Project Details and Scope

The work order encompasses glass, glazing and windows installation at Aakash Hospital's polyclinic facility located at Plot No. 150, Sector 12, Dwarka, New Delhi. The project has been awarded by LV Creations LLP, which has its registered office in South West Delhi.

Contract Terms and Timeline

The agreement includes specific performance-based billing terms, with the project scheduled for completion within 6 months. The contract represents a domestic engagement, with all work to be executed at the hospital's polyclinic facility in Dwarka.

Regulatory Compliance

Faalcon Concepts Limited has confirmed that this order does not involve any related party transactions and operates on an arm's length basis. The company has also disclosed that no promoter or promoter group companies have any interest in LV Creations LLP, ensuring complete transparency in the business engagement.

Company Leadership

The regulatory filing was signed by Ekta Seth, Managing Director of Faalcon Concepts Limited, confirming the company's commitment to maintaining proper disclosure standards and regulatory compliance in all business operations.

Faalcon Concepts Limited has announced the withdrawal of its preferential issue plans following a board meeting held on January 09, 2026. The decision marks a strategic shift for the company as it looks to restructure its fundraising approach.

Board Meeting Outcomes

The board meeting, which commenced at 04:00 p.m. and concluded at 04:20 p.m., addressed several key agenda items. The directors approved the withdrawal of two significant preferential issues that were previously sanctioned by both the board and shareholders.

Previous Approvals and Timeline

The preferential issue was initially considered and approved by the board of directors at their meeting held on November 01, 2025. Subsequently, shareholders provided their approval at an Extra-Ordinary General Meeting conducted on November 28, 2025. The company had also submitted an application for "In-principal Approval" with BSE Limited, which was under process.

Strategic Restructuring Decision

The management attributed the withdrawal to recent business developments and prospects, stating their intention to restructure the preferential issue. The company emphasized that the proposed preferential issue now stands postponed rather than permanently cancelled.

Impact Assessment

Faalcon Concepts assured stakeholders that this withdrawal decision will not affect the company's financial stability, operations, or growth prospects. The management emphasized their commitment to maintaining transparency with all stakeholders throughout this process.

Regulatory Compliance

The announcement was made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company communicated the decision to BSE Limited, where it trades under scrip code 544164, ensuring proper regulatory disclosure protocols were followed.